Local Infiltration of Tranexamic Acid With Local Anesthetic Reduces Intraoperative Facelift Bleeding: A Preliminary Report.
Rebound bleeding as a result of loss of epinephrine effect is a common problem encountered during facelift surgery. Tranexamic acid (TXA) is an anti-fibrinolytic agent whose safety and efficacy in reducing bleeding is well documented. We have found that local infiltration of TXA combined with a lidocaine with epinephrine solution during facelift surgery has been effective in decreasing rebound bleeding and the time required to gain hemostasis. To share our local infiltration protocol of TXA combined with epinephrine solution in facelift. Patients undergoing facelift received subcutaneous injection of TXA-lidocaine 0.5% solution following our protocol. After completing both sides of the facelift and the submental platysmaplasty, the first and second sides were sequentially closed. The time to gain hemostasis on each side prior to closure was prospectively measured. Twenty-seven consecutive patients undergoing facelift surgery received local infiltration of TXA-lidocaine solution. In 23 of the 27 patients the time required for hemostasis was prospectively recorded. The mean age was 62.1 years (±9.3) and all were females. The average time spent achieving hemostasis on the right, left, and both sides of the face was 6.5 (±2.7) minutes, 6.3 (±2.1) minutes, and 12.9 (±4.2) minutes, respectively. The total surgical time saving is approximately 25-60 minutes. Although primary facelift [13.6 (± 4.3)] exhibited a longer time of hemostasis compared to the secondary group [10.2 (± 2.8)], this was not statistically significant (p=0.09). Local infiltration of TXA with local anesthetic prior to a facelift appears to decrease bleeding, operative time, and postoperative facelift drainage output.